[[abstract]]Interleukin (IL)-20 is a proinflammatory cytokine involved in rheumatoid arthritis, atherosclerosis, and osteoporosis. However, the role of IL-20 in hepatocellular carcinoma (HCC) is unclear. We explored the function of IL-20 in HCC. Tumor tissue samples were analyzed the expression of IL-20 and cyclin D1 by using immunohistochemistry staining and quantitative real-time polymerase chain reaction (qRT-PCR) analysis. To examine the role of anti-IL-20 monoclonal antibody (7E) in tumor growth, BALB/c mice was injected with ML-1 cells and treated with 7E. HCC tumor tissue expressed higher levels of IL-20 than did non-tumor tissue. High IL-20 expression in HCC was correlated with poor overall survival (relative risk:>3). IL-20 and cyc...
Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from dif...
Objective—Atherosclerosis is a chronic inflammatory disease with immune cell infiltration. Various c...
Unveiling key oncogenic events in malignancies is the key to improving the prognosis and therapeutic...
[[abstract]]Interleukin (IL)-20 is a proinflammatory cytokine involved in rheumatoid arthritis, athe...
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction of arti...
<div><p>Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction...
Interleukin (IL)-20 is a proinflammatory cytokine in the IL–10 family. IL–20 is associated with tumo...
The three main causes of inflammation and chronic injury in the liver are viral hepatitis, alcohol c...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor...
Background: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor...
Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor prognosis, ...
<p>Liver cancer is a devastating disease that is the 5th most common cancer in men, 7th most common ...
Background & Aims: Different immune cells in tumor microenvironment shape tumor progression. CCL...
Hepatocellular carcinoma (HCC) ranks among the five most common cancer entities worldwide and leads ...
Hepatocellular carcinoma (HCC) is the primary form of liver cancer and a leading cause of cancer-rel...
Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from dif...
Objective—Atherosclerosis is a chronic inflammatory disease with immune cell infiltration. Various c...
Unveiling key oncogenic events in malignancies is the key to improving the prognosis and therapeutic...
[[abstract]]Interleukin (IL)-20 is a proinflammatory cytokine involved in rheumatoid arthritis, athe...
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction of arti...
<div><p>Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction...
Interleukin (IL)-20 is a proinflammatory cytokine in the IL–10 family. IL–20 is associated with tumo...
The three main causes of inflammation and chronic injury in the liver are viral hepatitis, alcohol c...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor...
Background: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor...
Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor prognosis, ...
<p>Liver cancer is a devastating disease that is the 5th most common cancer in men, 7th most common ...
Background & Aims: Different immune cells in tumor microenvironment shape tumor progression. CCL...
Hepatocellular carcinoma (HCC) ranks among the five most common cancer entities worldwide and leads ...
Hepatocellular carcinoma (HCC) is the primary form of liver cancer and a leading cause of cancer-rel...
Hepatocellular carcinoma (HCC) is associated with chronic inflammation and fibrosis arising from dif...
Objective—Atherosclerosis is a chronic inflammatory disease with immune cell infiltration. Various c...
Unveiling key oncogenic events in malignancies is the key to improving the prognosis and therapeutic...